Non-Nicotine Replacement Therapy

Varenicline (branded as Chantix and Champix) is a medication prescribed to patients to treat nicotine addiction which you begin taking 1 to 2 weeks before your set quit date and usually lasts over a period of 8-12 weeks, both reducing cravings for and decreasing the pleasurable effects of cigarettes and tobacco. It is a high-affinity partial agonist for the alpha-4 beta-2 nicotinic acetylcholine receptor subtype (nACH) that leads to the release of dopamine in the nucleus accumbens when activated, and therefore, has the capacity to reduce the craving and withdrawal symptoms caused by smoking cessation. In this respect it is different from the nicotine replacement therapies (NRTs) we provide such as nicotine patches, sprays and gum.

Varenicline is not available for pregnant women nor anyone under the age of 18, around 1 in 3 people suffer mild nausea as a result of this medication but it is not necessary to discontinue use unless the symptoms persist. Other less common side effects include constipation, headaches, sleeping difficulties and nightmares.

Scare stories got you worried about using some of these products? Check our myth buster to help separate the fact from fiction.

< Back to Stop Smoking Products

Latest News

vape-2439322_1280 Vaping and lung disease in the US: PHE’s advice

What’s happening in the US? Since mid-September, headlines around the world have warned about an outbreak of serious lung disease across the US, said to…

Read more >
Stoptober image Helping you split up with smoking this October

Breaking up is never easy but remember, it’s not you, it’s them! Whether you are 3 weeks in, or just starting off.. explore the free support…

Read more >
StoptoberApp Give quitting a go this Stoptober!

Stoptober is back for its eighth year, calling on England’s millions of smokers to split up from smoking for 28 days, starting on 1st October…

Read more >